Engineered Probiotic Bacteria Show Promise Against Ebola Especially as a Prophylactic
Nikhil Prasad Fact checked by:Thailand Medical News Team May 20, 2026 51 minutes ago
Medical News: Scientists from the Nebraska Center for Virology, the School of Biological Sciences at the University of Nebraska-Lincoln, and the School of Veterinary Medicine and Biomedical Sciences at the University of Nebraska-Lincoln have developed genetically engineered probiotic bacteria that may one day help prevent Ebola virus infections in a simple and affordable way.
Scientists engineer friendly probiotic bacteria capable of trapping and neutralizing Ebola-like viruses in laboratory studies
The research focused on modifying harmless lactic acid bacteria so they could carry a powerful antiviral protein called scytovirin on their surface. Scytovirin is a natural protein originally discovered in cyanobacteria and is already known for its ability to strongly block Ebola viruses.
A New Way to Fight Ebola
Ebola remains one of the world’s deadliest infectious diseases, with mortality rates that can reach as high as 90 percent during some outbreaks. Although vaccines and antibody-based treatments now exist, access remains limited in many low-resource regions where outbreaks commonly occur.
The researchers wanted to create a low-cost biological shield that could stay inside the human body and continuously trap viruses before they infect cells. Their idea was surprisingly simple: turn friendly probiotic bacteria into virus-catching machines.
The team engineered two bacterial species commonly considered safe for humans: Lactobacillus casei and Lactococcus lactis. Both are widely used in fermented foods and probiotic products.
How The Modified Bacteria Work
The scientists inserted the scytovirin gene into the bacteria so the antiviral protein would appear on the outer surface of each bacterial cell. This allows the bacteria to physically grab Ebola viral particles and stop them from attaching to human cells.
To test whether the system worked, the researchers used laboratory-made Ebola-like pseudoviruses. These viruses mimic Ebola infection but are safer to study. The modified bacteria successfully captured and neutralized the viral particles in laboratory experiments.
The Lactococcus lactis strain produced the strongest results. More than 92 percent of the engineered bacteria successfully displayed scytovirin on their surfaces. The bacteria were able to absorb about 38 percent of the viral particles and reduce infection by more than 53 percent in cell-based experiments. By comparison, ordinary non-engineered bacteria showed only weak natural protection.
Why One Bacterial Strain Performed Better
The researchers discovered that the Lactobacillus casei version was less stable genetically. Only about one-third of those bacteria displayed the antiviral protein correctly.
The team believes this happened because the bacteria gradually lost the engineered genetic material during growth. Another issue was that a fluorescent marker protein called GFP may have partially blocked scytovirin from efficiently binding to viruses.
To solve this, the scientists removed the bulky GFP protein in the s
econd bacterial design used in Lactococcus lactis. This made the antiviral protein more exposed and effective.
The improvement was dramatic.
Confocal microscopy and flow cytometry tests clearly showed strong surface expression of scytovirin across almost the entire bacterial population.
Potential Real-World Benefits
One major advantage of this strategy is that lactic acid bacteria can naturally survive on mucosal surfaces such as the mouth, nose, intestines, and digestive tract. These are often the same entry points used by dangerous viruses.
Because the bacteria can colonize the body, they may provide long-term antiviral protection instead of short-term treatment alone.
The researchers also noted that this method could be especially useful in developing countries because it is relatively inexpensive, easy to produce, and simple to distribute without requiring advanced medical infrastructure.
Importantly, this
Medical News report highlights that the engineered bacteria act like living antiviral barriers rather than conventional drugs.
The researchers are now planning future animal studies to determine whether the bacteria can survive inside the body long enough to provide meaningful protection against real Ebola infection.
Researchers Hope for Future Human Applications
The scientists believe this probiotic-based technology could eventually become a preventive treatment administered orally, nasally, or even rectally depending on the target infection route.
They also suggested the same bacterial engineering approach may later be adapted to fight other dangerous viruses beyond Ebola.
The study’s conclusions were highly encouraging. The researchers demonstrated that harmless probiotic bacteria can successfully be transformed into antiviral delivery systems capable of capturing and neutralizing Ebola-like viruses. While the current work was limited to laboratory experiments, the findings provide strong proof that engineered commensal bacteria may become a new class of low-cost antiviral defense tools. If future animal and human studies confirm safety and effectiveness, this technology could offer long-lasting protection in outbreak regions where access to expensive medicines remains limited.
The study findings were published in the peer reviewed journal: Frontiers in Microbiology.
https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2023.1269869/full
For the latest Ebola news, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/scientists-discover-potential-ebola-blocking-effects-of-lumateperone
https://www.thailandmedical.news/news/pink-rockrose-compounds-show-promise-against-ebola
https://www.thailandmedical.news/news/old-gout-drug-shows-promise-against-ebola
https://www.thailandmedical.news/news/study-finds-that-berberine-hydrochloride-could-be-used-to-inhibit-ebola-virus
https://www.thailandmedical.news/news/the-phytochemical-kolaviron-from-garcinia-kola-bitter-kola-shows-potential-against-the-ebola-virus-further-studies-needed
https://www.thailandmedical.news/news/u-s-nih-study-finds-that-algal-lectin-griffithsin-shows-promise-in-preventing-ebola-virus-infection
Medical Disclaimer: All content published by Thailand Medical News is based on scientific research and is intended for informational and educational purposes only. It is not medical advice, diagnosis, or treatment. Readers must not attempt to use, apply, or experiment with any protocols, compounds, or therapies mentioned without first consulting a qualified and licensed medical doctor. Many findings discussed are experimental or preliminary, and only a licensed healthcare professional can determine what is safe and appropriate for an individual’s specific medical condition.
Share
Tweet
Share
